Aethlon Medical (AEMD) Cash & Equivalents Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Aethlon Medical | 1.14 Mn | -5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -10.60% |
| Sep 30, 2025 | -16.28% |
| Jun 30, 2025 | -24.47% |
| Mar 31, 2025 | -10.55% |
| Dec 31, 2024 | 3.89% |
| Sep 30, 2024 | 54.24% |
| Jun 30, 2024 | 29.49% |
| Mar 31, 2024 | 7.63% |
| Dec 31, 2023 | 10.56% |
| Sep 30, 2023 | 15.11% |
| Jun 30, 2023 | 16.22% |
| Mar 31, 2023 | 15.96% |
| Dec 31, 2022 | 25.55% |
| Sep 30, 2022 | 84.54% |
| Jun 30, 2022 | 114.68% |
| Mar 31, 2022 | 61.55% |
| Dec 31, 2021 | 100.72% |
| Sep 30, 2021 | 110.92% |
| Jun 30, 2021 | 81.11% |
| Mar 31, 2021 | 36.08% |
| Dec 31, 2020 | 30.23% |
| Sep 30, 2020 | 28.02% |
| Jun 30, 2020 | 22.71% |
| Mar 31, 2020 | 62.20% |
| Dec 31, 2019 | 7.89% |
| Sep 30, 2019 | 8.35% |
| Jun 30, 2019 | 25.29% |
| Mar 31, 2019 | 25.08% |
| Dec 31, 2018 | 21.07% |
| Sep 30, 2018 | 257.03% |
| Jun 30, 2018 | 186.62% |
| Mar 31, 2018 | 123.42% |
| Dec 31, 2017 | 120.37% |
| Sep 30, 2017 | 27.62% |
| Jun 30, 2017 | -11.30% |
| Mar 31, 2017 | 61.06% |
| Dec 31, 2016 | 12.12% |
| Sep 30, 2016 | 64.94% |
| Jun 30, 2016 | 149.39% |
| Mar 31, 2016 | 166.82% |
| Dec 31, 2015 | 69.23% |
| Sep 30, 2015 | 53.96% |
| Jun 30, 2015 | 145.31% |